Amundi reduced its position in shares of Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 34.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 204,637 shares of the real estate investment trust's stock after selling 106,634 shares during the period. Amundi owned approximately 0.06% of Healthcare Realty Trust worth $3,409,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of HR. BNP Paribas Financial Markets acquired a new position in Healthcare Realty Trust during the fourth quarter worth about $2,504,000. Cresset Asset Management LLC acquired a new position in Healthcare Realty Trust during the 4th quarter worth approximately $356,000. Deutsche Bank AG increased its position in Healthcare Realty Trust by 95.9% during the 4th quarter. Deutsche Bank AG now owns 464,941 shares of the real estate investment trust's stock worth $7,881,000 after purchasing an additional 227,566 shares in the last quarter. Focus Partners Wealth increased its position in Healthcare Realty Trust by 23.5% during the 4th quarter. Focus Partners Wealth now owns 20,254 shares of the real estate investment trust's stock worth $352,000 after purchasing an additional 3,850 shares in the last quarter. Finally, Lazard Asset Management LLC acquired a new position in Healthcare Realty Trust during the 4th quarter worth approximately $45,000.
Analyst Ratings Changes
HR has been the subject of several research analyst reports. BTIG Research reiterated a "buy" rating and set a $20.00 price target on shares of Healthcare Realty Trust in a report on Wednesday, September 10th. Wall Street Zen cut Healthcare Realty Trust from a "hold" rating to a "sell" rating in a report on Saturday, May 31st. JPMorgan Chase & Co. lowered their target price on Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating for the company in a report on Thursday, June 26th. Wells Fargo & Company upped their target price on Healthcare Realty Trust from $15.00 to $16.00 and gave the stock an "underweight" rating in a report on Wednesday, August 27th. Finally, Raymond James Financial downgraded Healthcare Realty Trust from a "market perform" rating to an "underperform" rating in a research note on Monday. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $17.67.
Read Our Latest Report on Healthcare Realty Trust
Insider Activity at Healthcare Realty Trust
In other Healthcare Realty Trust news, EVP Julie F. Wilson sold 15,000 shares of the firm's stock in a transaction on Friday, September 5th. The shares were sold at an average price of $18.00, for a total value of $270,000.00. Following the completion of the sale, the executive vice president directly owned 113,419 shares in the company, valued at approximately $2,041,542. This trade represents a 11.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Thomas N. Bohjalian purchased 10,000 shares of Healthcare Realty Trust stock in a transaction on Wednesday, August 13th. The stock was bought at an average price of $16.46 per share, with a total value of $164,600.00. Following the completion of the acquisition, the director directly owned 75,520 shares of the company's stock, valued at approximately $1,243,059.20. This trade represents a 15.26% increase in their position. The disclosure for this purchase can be found here. Company insiders own 0.37% of the company's stock.
Healthcare Realty Trust Trading Up 0.7%
NYSE:HR traded up $0.13 on Wednesday, reaching $17.92. 3,551,573 shares of the stock traded hands, compared to its average volume of 3,873,761. The firm has a market capitalization of $6.30 billion, a price-to-earnings ratio of -15.58 and a beta of 0.94. The company's 50 day moving average is $16.86 and its 200-day moving average is $16.03. Healthcare Realty Trust Incorporated has a 1-year low of $14.09 and a 1-year high of $18.82.
Healthcare Realty Trust (NYSE:HR - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Healthcare Realty Trust had a negative return on equity of 7.70% and a negative net margin of 32.95%.The firm had revenue of $287.07 million during the quarter, compared to the consensus estimate of $290.83 million. During the same period last year, the business posted $0.38 EPS. Healthcare Realty Trust has set its FY 2025 guidance at 1.570-1.610 EPS. On average, equities research analysts forecast that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current fiscal year.
Healthcare Realty Trust Cuts Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th were given a dividend of $0.24 per share. The ex-dividend date of this dividend was Thursday, August 14th. This represents a $0.96 annualized dividend and a dividend yield of 5.4%. Healthcare Realty Trust's dividend payout ratio (DPR) is -83.48%.
About Healthcare Realty Trust
(
Free Report)
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
Recommended Stories

Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.